Pharmacopsychiatry Journal
banner
pharmacopsychiatry.bsky.social
Pharmacopsychiatry Journal
@pharmacopsychiatry.bsky.social
Pharmacopsychiatry is a leading international Thieme journal focused on the field of psychotropic drugs. The journal is the official publishing organ of the AGNP.

https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000054
This systematic #review offers a more comprehensive overview of the safety and tolerability profile of an emerging treatment for adults with schizophrenia:

🔗 www.thieme-connect.de/products/ejo...
November 14, 2025 at 4:16 PM
A study in our latest issue seeks to clarify how low-grade inflammation influences the antidepressant and antisuicidal effects of low-dose ketamine infusion in patients with treatment-resistant depression. Find out more at the link below!

📖 www.thieme-connect.de/products/ejo...
November 3, 2025 at 10:25 AM
#Celebrating a #milestone today - we reached our 1000 follower mark this week!

Thank you for your engagement with our channel and we look forward to sharing much more with you soon!
August 29, 2025 at 9:09 AM
🧠 In this study, the #feasibility of implementing #Measurement-BasedCare was assessed for #patients with #MajorDepressiveDisorder seen in a large #outpatient #psychiatry #clinic.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
July 18, 2025 at 1:21 PM
💊 This systematic review investigates the instruments measuring #medicationliteracy (ML) in #psychiatric #patients and their #caregivers.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
July 4, 2025 at 3:46 PM
🐁 Three #NOX #isotypes are expressed mainly in the #brain: NOX2, NOX3 and NOX4, this study explored the expression and #cellular sources of these NOX #isoforms was investigated in the context of stress-induced #depression.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
June 20, 2025 at 3:16 PM
🧠 Given the complicated procedure of the dex/CRH-test, this study aimed to develop a #genetic variants-based alternative approach to predict the outcome of the dex/CRH-test in acute #depression.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
June 6, 2025 at 9:17 AM
🧠 This narrative #review discusses how the safe and effective use of #clinicalAI #prediction tools requires recognition of the importance of human intelligence.

💻 Read the paper on our webpage: www.thieme-connect.com/products/ejo...
May 30, 2025 at 2:01 PM
‼️ 📢 Announcing Pharmacopsychiatry's Most Innovative Paper of 2024 📢 ‼️

Our wonderful Pharmacopsychiatry Editors and Advisory Board members have voted, and we are thrilled to announce that the winner of the first ever Most Innovative Paper award is... 🥁

💻 www.thieme-connect.com/products/ejo...
May 19, 2025 at 11:37 AM
💊 This study aims to determine the prevalence of Z-drug #prescribing among #Medicare Part D patients and identify state or specialty-dependent prescribing differences, along with determining prescribing patterns of Z-drugs to Medicare patients.

💻 www.thieme-connect.com/products/ejo...
May 16, 2025 at 3:26 PM
💊 Dose-related reference ranges can be used in #therapeutic #drug monitoring to monitor #pharmacotherapy.

💊 The serum concentrations of patients treated with #cariprazine regularly deviated from this dose-related reference range.

💻 www.thieme-connect.com/products/ejo...
May 9, 2025 at 1:48 PM
💊 Most research fails to distinguish between acquired and innate #resistance, with limited data on treatment resistance (TR) in first episode #psychosis (FEP).

💊 To further understand this, data of FEP patients with and without TR were compared.

💻 www.thieme-connect.com/products/ejo...
April 25, 2025 at 1:54 PM
💊 Currently available systematic reviews on the #pharmacological treatment of #AutismSpectrumDisorder (ASD) do not encompass all the evidence, as they exclude #guidelines issued by national or local authorities that are not indexed in search engines.

💻 www.thieme-connect.com/products/ejo...
April 11, 2025 at 1:23 PM
🍃 #Cannabidiol (CBD), a naturally occurring #cannabinoid, has been investigated in several #psychiatric conditions.

🍃 This review comprises a comprehensive literature search to identify clinical studies on the effects of #CBD in psychiatric conditions.

💻 www.thieme-connect.com/products/ejo...
April 4, 2025 at 12:19 PM
While hyperactive AVP/V1b signalling can be predicted with the dex/CRH-test, it's a complicated procedure. Authors evaluated the ability of a simple genetic test from blood as an alternative more accessible at point of care.

www.thieme-connect.com/products/ejo...
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression
Thieme E-Books & E-Journals
www.thieme-connect.com
March 29, 2025 at 1:21 PM
Real world blood levels of cariprazine are lower than predicted reference range, suggesting the range should be updated.

www.thieme-connect.com/products/ejo...
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range
Thieme E-Books & E-Journals
www.thieme-connect.com
March 29, 2025 at 1:15 PM
In a new meta-analysis, Xanomeline-Trospium, recently approved in the USA for adults with SCZ, demonstrated lower risk of AEs commonly associated with older medications for the treatment of SCZ such as wt gain, movement disorders, and sedation.

www.thieme-connect.com/products/ejo...
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes
Thieme E-Books & E-Journals
www.thieme-connect.com
March 29, 2025 at 1:12 PM
💊 Several randomized controlled trials (RCTs) have compared the effectiveness, efficacy, and safety of #antipsychotic #monotherapy (APM) versus placebo in patients with major depressive disorder, this #review conducts a meta-analysis to examine this topic.

💻 www.thieme-connect.com/products/ejo...
March 28, 2025 at 2:06 PM
💉 One of the first Reviews to study submaximal #prolactin responses to #Thyrotropin-releasing #hormone (TRH) and correlate #mini-TRH test results with key #psychotic symptoms, including memory dysfunction in inpatients hospitalized for acute #psychosis

💻 www.thieme-connect.com/products/ejo...
March 21, 2025 at 3:30 PM
💊 This retrospective cohort study was the first to investigate whether there was a difference in treatment discontinuation for #Japanese adults with #bipolar #disorder between the #lurasidone and #quetiapine treatment groups.

💻Read the article on: www.thieme-connect.com/products/ejo...
March 14, 2025 at 9:29 AM
Celebrating International Women's Day!

This #InternationalWomensDay, all of us at Pharmacopsychiatry celebrate the pivotal contributions of all #WomenInScience. We are committed to equity in research and innovation. To our editors, our authors, our readers, and our community - we appreciate you 💖
March 8, 2025 at 9:15 AM
💊 Partial response to #pharmacotherapy is common in major depressive disorder and many patients require alternative pharmacotherapy or augmentation, including adjunctive L-methylfolate, which is rarely included in major clinical practice guidelines.

💻 www.thieme-connect.com/products/ejo...
March 7, 2025 at 11:55 AM
📢 A fascinating #OpenAccess read for your #weekend!

💊 #Pharmacoepidemiological data suggest that #lithium prescriptions for #bipolar disorder are gradually decreasing, with less attention having been paid to other indications.

💻 www.thieme-connect.de/products/ejo...
February 28, 2025 at 1:03 PM
A great #OpenAccess #Review by Kirsten R. Müller-Vahl

🌿 This Review summarizes current research into #cannabis based #medicines and their potential for use in the #treatment of #psychiatric disorders.

📖 Read the full article online to find out more:
lnkd.in/gV7QvfRD
February 21, 2025 at 10:38 AM
📢 An #OpenAccess read for your #weekend!

💊 This study examines the treatment effects of Escitalopram and pharmacokinetic influences on blood levels, and highlights the potential of therapeutic drug monitoring to support decisions on dosing.

💻 www.thieme-connect.de/products/ejo...

#MentalHealth
February 14, 2025 at 12:38 PM